Enhancing Postoperative Analgesia in Breast Reduction Surgery: The Combined Effect of Pectointercostal Fascial Plane Block and Serratus Anterior Plane Block.

Authors

Ayşe İrem Bozkurt, İbrahim Tabakan, Feride Karacaer, Demet Laflı Tunay, Murat Ilginel, Ebru Biricik

Published in

Aesthetic plastic surgery. Aug 15, 2025. Epub Aug 15, 2025.

Abstract

Pectointercostal Fascial Plane Block (PIFB) targets the anterior cutaneous branches of the intercostal nerves and provides analgesia to the anteromedial chest wall. In this study, we aimed to evaluate the effect of PIFB in addition to Serratus Anterior Plane Block (SAPB) on postoperative morphine consumption and pain scores in breast reduction surgery.
Sixty-four ASA I-II patients (≥18 years) were randomly assigned to two groups. General anesthesia was induced with propofol, rocuronium, fentanyl, and maintained with sevoflurane and remifentanil. After intubation: Group I (PIFB + SAPB) received bilateral PIFB (15 mL 0.25% bupivacaine) and SAPB (20 mL 0.25% bupivacaine). Group II (SAPB only) received SAPB (20 mL 0.25% bupivacaine) only. Postoperative analgesia included IV morphine patient-controlled analgesia (1 mg bolus, 10-min lockout, 4-hour limit: 10 mg). Outcomes measured were stay in postanesthesia care unit time (PACU), 24-hour morphine consumption, morphine demands, VAS scores (rest and movement), additional analgesic use, and complications.
Both groups had similar demographics, surgical duration, and PACU stay. 24-hour morphine consumption was lower in Group I (3.7±2.2 mg vs. 7.9±2.3 mg, p<0.05). Morphine demands were lower in Group I (4.5±2.7 vs. 10.4±3.7, p<0.05). VAS scores (rest and movement) were lower in Group I (p<0.05). Rescue analgesic requirement was lower in Group I than in Group I (p=0.01). No complications occurred in both groups.
PIFB combined with SAPB significantly reduces morphine consumption and pain scores in breast reduction surgery without complications.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors  www.springer.com/00266 .

PMID:
40815379
Bibliographic data and abstract were imported from PubMed on 15 Aug 2025.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.